Phase 3 study finds once-daily valbenazine improves symptoms of tardive dyskinesia.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 7, p. 1, doi. 10.1002/pu.30240
- Publication type:
- Article
Works matching IS 10685308 AND DT 2017 AND VI 28 AND IP 7
Results: 7
1
2
Matching to preferred depression treatment does not improve likelihood of remission.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 7, p. 1, doi. 10.1002/pu.30241
- Publication type:
- Article
3
Mood stabilizers and risperidone.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 7, p. 2, doi. 10.1002/pu.30242
- By:
- Publication type:
- Article
4
Use of medications for enlarged prostate not associated with suicide risk.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 7, p. 3, doi. 10.1002/pu.30243
- Publication type:
- Article
5
Sodium valproate shown most effective as augmentation for clozapine.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 7, p. 4, doi. 10.1002/pu.30244
- Publication type:
- Article
6
Research Roundup.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 7, p. 7, doi. 10.1002/pu.30245
- Publication type:
- Article
7
Approvals.
- Published in:
- Brown University Psychopharmacology Update, 2017, v. 28, n. 7, p. 8, doi. 10.1002/pu.30246
- Publication type:
- Article